Researchers in Australia have identified six potential genes that may help explain why people with cystic fibrosis (CF) experience…
Michela Luciano, PhD
Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela holds a PhD in Molecular Biology from the University of Salzburg, where her research focused on the role of inflammation in acute myeloid leukemia. With a deep passion for scientific communication, Michela transitioned into her first role as a scientific writer in 2022. Outside of work, she enjoys street photography, mountain hikes, running, and spending as much time outdoors as possible.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Michela Luciano, PhD
People with cystic fibrosis (CF) who lost weight while taking GLP-1 receptor agonists (GLP-1 RAs) — medications commonly used…
Researchers in Italy have developed a new experimental compound called 3b, which has shown early promise as a dual-action therapy…
Vertex Pharmaceuticals presented new data highlighting additional clinical benefits and improved outcomes in people with cystic fibrosis (CF) treated…
In people with cystic fibrosis (CF), treatment with Kaftrio (elexacaftor, tezacaftor, and ivacaftor) may reduce the risk of CF-related liver…
Women with conditions such as cystic fibrosis (CF) who planned their pregnancies after a lung transplant experienced better outcomes…